COVID Variant HV.1 Becomes Dominant in the US, Vaccination Challenges Persist

Go [here]( to opt-out of our email list or mark as [SPAM](. Please add us to your address book or [whitelist us](. Directions for whitelisting are [here](. --------------------------------------------------------------- ---------------------------------------------------------------  FEATURED [FDA Advisers Evaluate CRISPR-Based Gene Therapy for Sickle Cell Disease](  In a significant step forward for medical innovation, advisers at the U.S. Food and Drug Administration (FDA) are currently evaluating a CRISPR-based gene therapy as a potential treatment for Sickle Cell Disease. This development holds great promise in the quest to address this inherited blood disorder.  Sickle Cell Disease is a genetic condition that causes red blood cells to take on an abnormal shape, leading to pain, anemia, and other serious health issues.  [Read More >>](  --------------------------------------------------------------- THIS WEEK'S TOP STORIES ...  [E. coli outbreak in San Diego linked to restaurant]( [UN agencies appeal for urgent aid access to Gaza amidst Israeli conflict]( [Israeli population grapples with mental health crisis amidst ongoing conflict]( --------------------------------------------------------------- ~Health Experts  --------------------------------------------------------------- You opted in to receive these emails when you requested information or entered one of our contests. You can [Manage Subcription]( here if you do not want to receive these emails any longer. To help make sure we make it into your inbox, add support@primehealthexperts.com to your address book.  This email was sent to {EMAIL} by support@primehealthexperts.com 296 Beauvoir Rd, Biloxi, MS 39531 [1-Click Unsubscribe]( | [Edit Profile]( | [Manage Subscriptions]( | [Report Spam](